Search for companies, drugs, and catalysts
Search for companies, drugs, and catalysts
Phase 3
Development Phase
0
Upcoming Catalysts
0
Historical Events
0
Regulatory Approvals
No catalyst events have been recorded for this drug yet.
0 competitors in Metastatic Castration Sensitive Prostate Cancer (mCSPC)
View Full LandscapeTarget Indication
Metastatic Castration Sensitive Prostate Cancer (mCSPC)
Clinical Trial
NCT07028853Last updated: 1/2/2026
No patent data available. Pre-approval drugs may not have Orange Book listings.
Vaccines, Pneumococcal
Renal Transplantation
Diabetes Mellitus
Major Depressive Disorder
Complicated Intra-abdominal Infections